| Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke W Hacke, M Kaste, E Bluhmki, M Brozman, A Dávalos, D Guidetti, ... New England journal of medicine 359 (13), 1317-1329, 2008 | 8867 | 2008 |
| Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery JW Moses, MB Leon, JJ Popma, PJ Fitzgerald, DR Holmes, ... New England Journal of Medicine 349 (14), 1315-1323, 2003 | 5994 | 2003 |
| Transcatheter or surgical aortic-valve replacement in intermediate-risk patients MB Leon, CR Smith, MJ Mack, RR Makkar, LG Svensson, SK Kodali, ... New England Journal of Medicine 374 (17), 1609-1620, 2016 | 5296 | 2016 |
| Alogliptin after acute coronary syndrome in patients with type 2 diabetes WB White, CP Cannon, SR Heller, SE Nissen, RM Bergenstal, GL Bakris, ... New England journal of medicine 369 (14), 1327-1335, 2013 | 3174 | 2013 |
| ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article: a report of the American … E Braunwald, EM Antman, JW Beasley, RM Califf, MD Cheitlin, ... Journal of the American College of Cardiology 40 (7), 1366-1374, 2002 | 2718 | 2002 |
| Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents L Mauri, DJ Kereiakes, RW Yeh, P Driscoll-Shempp, DE Cutlip, PG Steg, ... New England Journal of Medicine 371 (23), 2155-2166, 2014 | 2169 | 2014 |
| ACC/AHA guidelines for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction: a report of the American College of Cardiology … E Braunwald, EM Antman, JW Beasley, RM Califf, MD Cheitlin, ... Journal of the American College of Cardiology 36 (3), 970-1062, 2000 | 1771 | 2000 |
| ACC/AHA/NHLBI clinical advisory on the use and safety of statins Writing Committee Members:, RC Pasternak, SC Smith Jr, ... Circulation 106 (8), 1024-1028, 2002 | 1625 | 2002 |
| ACC/AHA guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—2002: summary article: a report of the American … Committee Members, E Braunwald, EM Antman, JW Beasley, RM Califf, ... Circulation 106 (14), 1893-1900, 2002 | 1606 | 2002 |
| Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the … PA Gurbel, KP Bliden, K Butler, US Tantry, T Gesheff, C Wei, R Teng, ... Circulation 120 (25), 2577-2585, 2009 | 1516 | 2009 |
| Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 … AM Lincoff, JA Bittl, RA Harrington, F Feit, NS Kleiman, JD Jackman, ... Jama 289 (7), 853-863, 2003 | 1484 | 2003 |
| ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)—executive summary: a report of the American College of Cardiology/American … SC Smith Jr, JT Dove, AK Jacobs, JW Kennedy, D Kereiakes, MJ Kern, ... Circulation 103 (24), 3019-3041, 2001 | 1435 | 2001 |
| Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate L Bonello, US Tantry, R Marcucci, R Blindt, DJ Angiolillo, R Becker, ... Journal of the American College of Cardiology 56 (12), 919-933, 2010 | 1372 | 2010 |
| Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis VH Thourani, S Kodali, RR Makkar, HC Herrmann, M Williams, ... The Lancet 387 (10034), 2218-2225, 2016 | 1173 | 2016 |
| Enoxaparin vs unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary … SYNERGY Trial Investigators Jama 292 (1), 45-54, 2004 | 1080 | 2004 |
| A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction EJ Topol, RM Califf, BS George, DJ Kereiakes, CW Abbottsmith, ... New England Journal of Medicine 317 (10), 581-588, 1987 | 1079 | 1987 |
| Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease GW Stone, A Rizvi, W Newman, K Mastali, JC Wang, R Caputo, ... New England Journal of Medicine 362 (18), 1663-1674, 2010 | 1047 | 2010 |
| ACC/AHA guidelines for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction: executive summary and recommendations: a report of … E Braunwald, EM Antman, JW Beasley, RM Califf, MD Cheitlin, ... Circulation 102 (10), 1193-1209, 2000 | 974 | 2000 |
| Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention RW Yeh, EA Secemsky, DJ Kereiakes, SLT Normand, AH Gershlick, ... Jama 315 (16), 1735-1749, 2016 | 964 | 2016 |
| Everolimus-eluting bioresorbable scaffolds for coronary artery disease SG Ellis, DJ Kereiakes, DC Metzger, RP Caputo, DG Rizik, PS Teirstein, ... New England Journal of Medicine 373 (20), 1905-1915, 2015 | 749 | 2015 |
